Hill Publishing Group | contact@hillpublisher.com

Hill Publishing Group

Location:Home / Journals / International Journal of Clinical and Experimental Medicine Research /

DOI:http://dx.doi.org/10.26855/ijcemr.2022.04.013

Clinical Observation of Electroacupuncture Combined with Irbesartan Tablets in the Treatment of Essential Hypertension (Hyperactive Liver Yang Syndrome)

Date: April 28,2022 |Hits: 193 Download PDF How to cite this paper

Xiaofang Wei1, Canni Pan1, Miaomiao Wu1, Jingyang Liu2,*

1Guangxi University of Traditional Chinese Medicine, Nanning, Guangxi, China.

2Ruikang Hospital affiliated to Guangxi University of Traditional Chinese Medicine, Nanning, Guangxi, China.

*Corresponding author: Jingyang Liu

Abstract

Objective: In this study, electroacupuncture was used to treat grade 1 primary hypertension (syndrome of hyperactive liver Yang) patients as the research object, and the scores of TCM symptoms, blood pressure and efficacy were compared before and after treatment. By observing the influence of electrotherapy on TCM symptom score, blood pressure value and curative effect judgment of primary hypertension patients (syndrome of hyperactive liver Yang) of grade 1, the experience is summarized to provide more theoretical basis for clinical practice. Methods: 60 patients with essential hypertension (syndrome of hyperactive liver Yang) were randomly divided into two groups, 30 patients in control group were treated with irbesartan tablets. The treatment group was treated with electroacupuncture combined with irbesartan tablets. Syndrome score and clinical efficacy were compared before and after treatment. Results: The improvement effect and treatment effect of TCM symptom in the treatment group were better than those in the control group (P<0.05). Conclusion: Electroacupuncture combined with Irbesartan tablets is effective in the treatment of essential hypertension (hyperactive liver Yang syndrome).

References

[1] Kearney, Patricia M., et al. (2005). “Global burden of hypertension: analysis of worldwide data.” Lancet (London, England), vol. 365, 9455(2005): 217-23.

[2] Organization W. H. (2021). World health statistics 2021: monitoring health for the SDGs, sustainable development goals [M]. 2021: 39-40.

[3] Messerli, F. H., Bangalore, S., Bavishi, C., et al. (2018). Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use? [J]. Journal of the American College of Cardiology, 2018, 71(13): 1474-1482.

[4] Zhong, Y., Tang, R., Lu, Y., et al. (2020). Irbesartan may relieve renal injury by suppressing Th22 cells chemotaxis and infiltration in Ang II-induced hypertension. Int Immunopharmacol., 2020; 87: 106789. 

[5] Whelton, P. K., Carey, R. M., Aronow, W. S., et al. (2017) ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/ PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [published correction appears in Hypertension. 2018 Jun; 71(6):e140-e144]. Hypertension, 2018, 71(6): e13-e115.

[6] Gao Shuzhong, Yang Jun editor-in-chief. (2016). Acupuncture therapy [M]. Beijing: China Traditional Chinese Medicine Press, 2016, 43-44.

[7] Wu Zhaosu, Huo Yong, Wang Wen, et al. (2014). Guidelines for education of hypertension patients in China [J]. Journal of Chronic Diseases, 2014, 15(01):1-30.

[8] Chen Yuantao. (2008). Routine Diagnosis and Treatment of TCM Diseases and Syndromes [M]. Nanjing: Southeast University Press, 2008:66-67.

[9] Wang Jie, He Qingyong. (2011). Combination of disease and Syndrome with TCM Syndrome [M]. Beijing: China Medical Science and Technology Press, 2011: 32-40.

[10] (Song) by Chen Wuze. (2011). Beijing: China Medical Science and Technology Press, 2011 01.107.

[11] (Ming) by Yang Jizhou. (2008). Compendium of Acupuncture and Moxibustion [M]. Shanxi Publishing Group; Taiyuan: Shanxi Science and Technology Press, 2008: 78-368.

[12] Li Jing, Liu Xiaowei, Li Peipei, et al. (2020). Clinical observation of baihui point penetrating acupuncture combined with Western conventional therapy in the treatment of essential hypertension [J]. Journal of Traditional Chinese Medicine, 2020, 26(07): 38-41.

[13] Yuan Jingyun, Ji Zhi, Wang Zijuan, et al. (2019). Effects of electroacupuncture “Taichong” and “Baihui” on the expression of ACE2 and Ang(1-7) and the ratio of Ang(1-7)/Ang ⅱ in renal tissues of spontaneous hypertension rats [J]. Clinical Journal of Acupuncture and Moxibustion, 2019, 35(03): 46-50+89.

[14] Ding, L. (2018). Effects of different intensities of electroacupuncture at Fengchi and Quchi points on NF-κB P65 protein and gene expression in essential hypertension rats [J]. Journal of Shanxi University of Traditional Chinese Medicine, 2018, 19(03): 20-23+39.

[15] Li T, Ji B. (2020). Effect of pressure at Siguan point on blood pressure in adult prehypertensive population [J]. Zhejiang Journal of Traditional Chinese Medicine, 2020, 55(04): 256-257.

[16] Wang Jin, Chen Jie, He Ali. (2020). Effect of acupuncture at sanyinjiao and juangu points on immediate antihypertensive effect of renal essence deficiency hypertension [J]. Clinical Medical Research & Practice, 2020, 5(10): 115-116.

[17] Wang Jing, Lin Xiaojie, Luo Xiaozhou, et al. (2016). Acupuncture at Taixi point reduces SHR blood pressure and regulates TNF-α and IL-6 protein expression in medulla oblongata [J]. Journal of Jinan University (Natural Science & Medicine), 2016, 37(04): 327-330.

[18] Shi Wai, Liu Boxun, Kong Xiangqing. (2020). Review of the international Society of Hypertension 2020 International Practice Guidelines for Hypertension [J]. Chinese Journal of Hypertension, 2020, 28(10): 912-914.

[19] Sanchis-Gomar, F., Lavie, C. J., Perez-Quilis, C., et al. (2019). Angiotensin-Converting Enzyme 2 and Antihypertensives (An-giotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019 [J]. MAYO Clinic Proceedings, 2020, 95(6): 1222-1230.

How to cite this paper

Clinical Observation of Electroacupuncture Combined with Irbesartan Tablets in the Treatment of Essential Hypertension (Hyperactive Liver Yang Syndrome)

How to cite this paper: Xiaofang Wei, Canni Pan, Miaomiao Wu, Jingyang Liu. (2022) Clinical Observation of Electroacupuncture Combined with Irbesartan Tablets in the Treatment of Essential Hypertension (Hyperactive Liver Yang Syndrome). International Journal of Clinical and Experimental Medicine Research6(2), 197-203.

DOI: http://dx.doi.org/10.26855/ijcemr.2022.04.013

Volumes & Issues

Free HPG Newsletters

Add your e-mail address to receive free newsletters from Hill Publishing Group.

Contact us

Hill Publishing Group

8825 53rd Ave

Elmhurst, NY 11373, USA

E-mail: contact@hillpublisher.com

Copyright © 2019 Hill Publishing Group Inc. All Rights Reserved.